-+ 0.00%
-+ 0.00%
-+ 0.00%

Exagen says systematic review finds AVISE Lupus test flags 25% of SLE cases missed by standard serology

PUBT·06/01/2026 13:02:16
Listen to the news
Exagen says systematic review finds AVISE Lupus test flags 25% of SLE cases missed by standard serology
  • Exagen announced publication of a systematic review validating real-world performance of its AVISE Lupus diagnostic algorithm; results have already been published.
  • The review found the test improved identification of systemic lupus patients versus conventional blood markers, supporting earlier, more confident diagnosis.
  • Findings were consistent across studies spanning 2011-2025, reinforcing the product’s clinical positioning for broader adoption.
  • Exagen said the expanded evidence base supports its reimbursement strategy and premium market positioning in autoimmune diagnostics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exagen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606010900PRIMZONEFULLFEED9729321) on June 01, 2026, and is solely responsible for the information contained therein.